Sabra Health Care REIT, Inc. (NASDAQ: SBRA) is a Real Estate company (REIT - Healthcare Facilities) with a market capitalization of $5.3B. The Maz Rating grades it against the other companies in its sector.
About three months ago (August 17, 2026), Sabra Health Care REIT, Inc. had a Maz Rating of 2.47 out of 5 (C, Hold), ranked against the other companies in its sector. Its strongest factor then was Profitability (3.69), above most of its sector; its weakest was Valuation (1.55), more expensive than most of its sector. The other factors: Momentum 3.03 (around the middle of its sector); Growth 3.02 (around the middle of its sector); Financial Health 3.01 (around the middle of its sector). The current rating is for members: log in to see it.
At $20.25, Sabra Health Care REIT, Inc. trades at 72.5x trailing earnings, 5.8x sales and 1.8x book value, with an EV/EBITDA of 18.7. Over the last twelve months it generated about $917M of revenue and $73M of net income. It runs a gross margin of 60.7%, an operating margin of 14.8% and a net margin of 7.8%. It shows return on equity of 2.6%, return on invested capital of 2.5% and a free cash flow yield of 6.8%. On the balance sheet: a debt-to-equity ratio of 0.86 and a current ratio of 0.32. Over the past 52 weeks the share price ranged from $17.54 to $22.77, with a beta of 0.64.
Sabra Health Care REIT, Inc. pays a dividend yielding 5.91%, with 423% of earnings paid out.
29 Wall Street analyst ratings cover the stock: 11 Buy, 16 Hold and 2 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.